Navigation Links
Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites by Year End
Date:8/7/2008

FREMONT, Calif., Aug. 7 /PRNewswire/ -- Velos, Inc., the recognized leader and trusted resource for clinical trial management information systems for large investigator sites, today announced it will cross the 50 percent market penetration threshold by year end. The company's flagship product, Velos eResearch, targets the needs of medical researchers with a particular focus on large academic medical research institutions with diverse user populations, and a wide variety of research information needs and challenges.

The measure uses the amount of NIH grant dollars awarded to Velos customers among the 100 largest such grant recipients who conduct clinical research. This group historically receives about 80 percent of total extramural NIH clinical research funding. The company's customers in this group receive 47 percent of NIH funding. Together with new Velos customers in contract stage, this figure will increase to just over 50 percent by year end. The figure only includes paying customers and excludes other research sites which may also use Velos eResearch as participants in clinical trials led by Velos customers. "Fifty percent is a pretty good level of market penetration to achieve five years from product launch, which reflects quite a bit of preparation work," observed John McIlwain, President and CEO of Velos, Inc.

While Velos eResearch was launched in 2003, the company spent years and millions of dollars between 1996 and 2003 designing and redesigning multiple iterations of the product before it launched. "It's taken years of work, singular focus, robust product design, and fabulous customers with great input to get to this stage," said Priti Sahai, MD, Velos Vice President of Product Development.

Now in Version 8, the robust Velos system allows large academic medical centers and research institutions -- that have unique and expansive requirements -- to apply Velos eResearch in a wide variety of creative and productive ways, in addit
'/>"/>

SOURCE Velos, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Velos to Develop Key System Interface for Clinical Research
2. Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Instrumentation Laboratory Receives FDA Clearance for HemosIL RecombiPlasTin 2G Assay
5. Rcadias COR Analyzer Family of Products Receives Second FDA Clearance
6. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
7. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
8. BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
9. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
10. Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium
11. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...INCETON, N.J., Nov. 25 P... pharmaceutical company committed to discovering, ...t viral infections, reported financial results for...ember 30, 2009 Pharmasset held $58.4 million in ca...,, Pipeline Update and 2009 Highlights ,, ...
(Date:11/25/2009)...CAGO and STAFA, Switzerland, Nov. 25 /PRNewswire/ ...acturer of innovative hearing solutions, presented... Conference, focusing on the special needs of the ...leading experts in aging and audiology from around...veryday with older people with hearing loss for an...
(Date:11/25/2009)...GEWATER, N.J., Nov. 25 The FDA gra...avirine) tablets, a non-nucleoside reverse transcr...RTI specifically indicated for use in treatment-ex...ilure with HIV-1 strains resistant to an NNRTI and...al approval is based on 48-week data from two Phas...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 54410 1Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 54410 2Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 54410 3Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 54410 4Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 54410 5Living Peacefully in a Big City 3A Natural Health Practitioner Offers Advice on Maintaining Sanity Health and Happiness 54408 1Living Peacefully in a Big City 3A Natural Health Practitioner Offers Advice on Maintaining Sanity Health and Happiness 54408 2Living Peacefully in a Big City 3A Natural Health Practitioner Offers Advice on Maintaining Sanity Health and Happiness 54408 3Institute Chastises Congress on Health Care Reforms Offers Five Point Program for Reducing Health Care Costs by 50 25 54406 1Institute Chastises Congress on Health Care Reforms Offers Five Point Program for Reducing Health Care Costs by 50 25 54406 2
...Technologies, Inc. (Nasdaq: NTII ) (NTI(R)) today.... ("Celtic Pharma") presented interim results,for ...of Neuro-Oncology., Paul Freiman, President and C...ased with our continuing involvement in the develo... which is so urgently needed.", On December 4, 20...
...iled to Reach Statistical ...EY HILLS, Mass., Dec. 5 /PRNewswire-,FirstCall/ --...and its,wholly- owned subsidiary, Unither Pharmace...heir two pivotal trials of OvaRex(R) MAb for the,t...nalysis demonstrates,that the studies failed to re...
Other Medicine Technology:Celtic Pharma Provides Update on XERECEPT(R) Clinical Program 2Celtic Pharma Provides Update on XERECEPT(R) Clinical Program 3Celtic Pharma Provides Update on XERECEPT(R) Clinical Program 4Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 2Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 3Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 4
(Date:11/27/2009)...facturers who use medical load cells at the heart ...y bringing in technology partner Flintec early in ...ve medical manufacturers are calling in Flintec lo...ects, ensuring that progress will not be constrain...dated technology. , (PRWE...
(Date:11/26/2009)...RNewswire/ -- The diabetes population in the Unite... and annual medical spending on the disease is pro...oday, according to a study published in the Decemb...ng Diabetes ® Program (NCDP), a program of No...om the University of Chicago. ,, According to t...
(Date:11/26/2009)...ead to strains or worse , , THURSDAY, No...ng with stuffing your turkey full to bursting, but... suitcase as you pack for holiday trips. , More...ospital emergency rooms, doctors, offices, clinics...injuries, such as muscle strains, pulls and tears,...
(Date:11/26/2009)...f the Live Life Again Center, a practice offering ...ng number of physicians who are taking advantage ... individuals who are interested in surgical weight...s utilizing Facebook to share before-and-after pho...mmunity. , Dallas, TX (Vo...
(Date:11/26/2009)...is, P.A. is offering free nationwide confidential ...ntrol pills who have suffered a Deep Vein Thrombos... or other related cardiac issues or had their Gall...-856-6405 or go to the firm’s website at ht... evaluation form. , (PRWE...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
...d man’, ‘old fogies’ and other such, this is not t.../. Surprisingly, it’s older people who are more op...t people become more positive as they get older, a... to look at several images for a few seconds. Duri...
...newly diagnosed breast cancer patients is responsi...ery// in the United States, according to a new stu...NCER, a peer-reviewed journal of the American Canc...me of treatment planning. Despite the fact t...
... one by parliamentarians of Britain and India, vis... "Even though TB is easily curable, over 1.5 m... We think parliamentarians of Britain and India mu...a five-member team to India for a firsthand look a...
...wing (MI), can be used to reduce alcohol abuse by ...al drinking age//, according to Psychologists. ...ide students in a process of resolving a situation...gnizing the discrepancies between their current be...
...ll Cornell Medical College could prove a potent we...e compound, called SS31, is able to cross the bloo...lecule recently linked to stroke-related tissue da... affected," says the study's lead author Dr. Sungh...
...ned people that at least 90 people have been attac...// in the island republic. They said the species l...ssels among others. The warning came in the ...ingapore 12 hours after he was infected with Vibri...
Other Medicine News:Health News:Breast Cancer Patients Unaware of Reconstructive Surgery 2Health News:British MP Stress the Need to Fight Against TB Jointly With India 2Health News:Motivational Interviewing Could Reduce Excessive Drinking by Students 2Health News:Antioxidant Molecule Could Help Minimize Stroke-Linked Brain Damage 2
Atraumatic Grasping Forceps (Fallopian), dual-incision
Optima III 45 Noninsulated Strong Forceps, with ratchet
Snap-In Snap-Out®-II Angulated Dissecting Forceps
Snap-In Snap-Out®-II Micro Dolphin Dissecting Forceps Insert
Medicine Products: